Skip to main content
. 2021 Sep 29;67:14–20. doi: 10.1016/j.jcrc.2021.09.007

Table 1.

Main patients' characteristics.

Global (n = 32) Alive (n = 15) Dead (n = 17) p Value
Male sex (n°, %) 25 (78) 9 (36) 16 (64)
Age (years) 63.9 ± 7.4 61.4 ± 7.0 66.1 ± 7.2 0.077
BMI (kg/m2) 27.2 ± 5.6 27.7 ± 6.7 26.9 ± 4.6 0.705
SAPS II (points) 32 ± 10 31 ± 10 33 ± 11 0.552
SOFA (points) 6.3 ± 2.4 6.2 ± 2.5 6.4 ± 2.5 0.872
Onset to hospital (days) 10.3 ± 7 9.9 ± 8 10.7 ± 6.1 0.762
NIV duration (days) 2.2 ± 2.5 2.4 ± 3.1 1.9 ± 1.8 0.609
Onset to ETI (days) 12.5 ± 6 11.9 ± 9.1 11 ± 7.2 0.832
PEEP (cmH2O) 9.8 ± 1.4 9.8 ± 1.9 9.8 ± 0.8 0.975
FiO2 0.75 ± 0.2 0.74 ± 0.2 0.75 ± 0.2 0.805
ETCO2/PaCO2 0.72 ± 0.11 0.75 ± 0.07 0.70 ± 0.12 0.174
PaO2/FiO2 (mmHg) 117.6 ± 39.9 127.7 ± 51.4 107.5 ± 26.1 0.458
C reactive protein (mg/L) 116 ± 88 113 ± 95 119 ± 85 0.842
Fluid balance (ml/day) 1111 ± 598 847 ± 531 1344 ± 567 0.0164
Urinary protein output (g/day) 88.3 ± 38.7 73.7 ± 37.6 101.1 ± 35.9 0.0441